Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IHP with Melphalan and FOLFOX4 for Unresectable Colorectal Liver Metastases
NCT00103298Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in colorectal cancer (CRC), sponsored by National Cancer Institute. Started Dec 2004; status: completed.
02
Drugs
melphalan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00103298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103298.